Atlas Trials

Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

Clinical trial NCT05656469 · RECRUITING

Trial details

NCT number
NCT05656469
Sponsor
Parnassia Groep
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Mood DisordersAnxiety DisordersPsychotic Disorders
Start date
2023-02-23
Primary completion
2026-09-01
Enrollment
2500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.